← All trials
NCT00002930
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 1996
- Primary completion
- Oct 1, 2002
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- 75
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Cornell UniversityLead sponsor
- Cornell UniversityStudy chair
- National Cancer Institute (NCI)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.